Division of Hepatology, Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden.
Unit of Gastroenterology and Rheumatology, Department of Medicine Huddinge (MedH), Karolinska Institutet, Stockholm, Sweden.
Liver Int. 2019 Feb;39(2):382-388. doi: 10.1111/liv.14007. Epub 2018 Dec 2.
Detection of early cholangiocarcinoma (CCA) in primary sclerosing cholangitis (PSC) is challenging. The aim of this study was to evaluate the diagnostic accuracy of a stepwise approach to biliary brush cytology with sequential use of fluorescence in-situ hybridization (FISH) for the detection of biliary malignancy in PSC.
We retrospectively studied consecutive patients with PSC who underwent biliary brushings at Karolinska University Hospital between 2009 and 2015 (n = 208). Brush samples were categorized as benign, equivocal (atypical or suspicious) and malignant. Equivocal cases were further analysed with FISH. Samples with a malignant cytology or positive FISH were considered positive. The diagnosis was determined after 12 months of follow-up.
The diagnosis CCA was confirmed in 15 patients (7%), high-grade dysplasia in three patients, and low-grade dysplasia in five patients at follow-up. Using the diagnostic algorithm, the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) for a diagnosis of CCA were 80% (95%CI 52%-96%), 96% (95%CI 92%-98%), 60% (95%CI 36%-81%) and 98% (95% CI 95%-100%). In patients with equivocal cytology (n = 61), the sensitivity for CCA diagnosis increased to 100% (95%CI 72%-100%) with a lower PPV of 58% (95%CI 34%-78%). The diagnostic accuracy for detection of CCA in all patients was 95% (95%CI 91%-97%).
Biliary brush cytology with sequential use of FISH in equivocal cases seems to be a highly predictive diagnostic test for CCA in PSC. These results support the use of FISH when cytology is equivocal for detection of biliary malignancy in PSC.
原发性硬化性胆管炎(PSC)中早期胆管癌(CCA)的检测具有挑战性。本研究的目的是评估胆道刷检细胞学联合荧光原位杂交(FISH)逐步检测PSC 胆道恶性肿瘤的诊断准确性。
我们回顾性研究了 2009 年至 2015 年在卡罗林斯卡大学医院接受胆道刷检的连续 PSC 患者(n=208)。将刷检标本分为良性、不确定(非典型或可疑)和恶性。不确定病例进一步进行 FISH 分析。细胞学检查为恶性或 FISH 阳性的病例被认为是阳性。诊断结果在随访 12 个月后确定。
15 例(7%)患者在随访中被确诊为 CCA,3 例为高级别异型增生,5 例为低级别异型增生。使用该诊断算法,CCA 的诊断灵敏度、特异性、阳性预测值(PPV)、阴性预测值(NPV)分别为 80%(95%CI 52%-96%)、96%(95%CI 92%-98%)、60%(95%CI 36%-81%)和 98%(95%CI 95%-100%)。在细胞学不确定(n=61)的患者中,CCA 诊断的灵敏度提高至 100%(95%CI 72%-100%),PPV 降至 58%(95%CI 34%-78%)。所有患者诊断 CCA 的准确性为 95%(95%CI 91%-97%)。
胆道刷检细胞学联合 FISH 对不确定病例进行检测似乎是一种高度预测性的诊断试验,可用于检测 PSC 中的 CCA。这些结果支持在细胞学不确定时使用 FISH 检测 PSC 中的胆道恶性肿瘤。